维美德医疗完成了1320万美元的股票回购,于2025年9月23日回购了198万股. Viemed Healthcare completed its $13.2 million share repurchase, buying back 1.98 million shares on Sept. 23, 2025.

2025年9月23日, Viemed保健公司(VMD)完成了其股份回购计划,购回并取消了198万股,约占未清股份的5%,总成本为1 320万美元,平均每股6.69美元。 Viemed Healthcare (VMD) completed its share repurchase program on September 23, 2025, buying back and canceling 1.98 million shares—about 5% of outstanding shares—at a total cost of $13.2 million, or $6.69 per share on average. 该方案于2025年6月9日由董事会批准,反映了公司对其长期前景和对股东价值的承诺的信心,并辅之以强劲的资产负债表和不断增长的自由现金流。 The program, approved by the board on June 9, 2025, reflects the company’s confidence in its long-term prospects and commitment to shareholder value, backed by a strong balance sheet and growing free cash flow. 维米德在美国各地提供家庭内呼吸道护理服务,包括睡眠治疗、非侵入性通风、临床人员和设备支助,使用技术和以病人为中心的护理。 Viemed provides in-home respiratory care services across the U.S., including sleep therapy, non-invasive ventilation, clinical staffing, and equipment support, using technology and patient-centered care. 该公司预计将继续投资于增长和回流资本,但未来的结果可能因经济状况、监管变化、偿还风险、网络安全威胁和市场波动而有所不同。 The company expects to continue investing in growth and returning capital, though future results may vary due to economic conditions, regulatory changes, reimbursement risks, cybersecurity threats, and market volatility.